The cash deal comes on the heels of Bristol-Myers Squibb Co's agreement last week to buy Celgene Corp for $74 billion in the largest pharmaceutical deal ever
Eli plans to bring some of its molecules from the global pipeline to India, especially in the oncology and diabetes space